AF
APYX icon

Amalgamated Financial’s Apyx Medical APYX Stock Holding History

Amalgamated Financial’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$33K Buy
+5,094
New +$50.2K ﹤0.01% 2585

Other funds holding APYX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Amalgamated Financial's APYX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Apyx Medical (APYX) in Q1 2022: 5,094 shares worth $33K. The stake represents ﹤0.01% of the portfolio and ranks #2585 among its holdings.

71 funds tracked by Wall St. Rank hold APYX as of Q1 2022.

  • Amalgamated Financial held 5,094 shares of Apyx Medical worth $33K as of Q1 2022.
  • Apyx Medical was a new Amalgamated Financial position in Q1 2022.
  • Apyx Medical made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2585 holding.
  • 71 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.